BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hayward KL, Weersink RA. Improving Medication-Related Outcomes in Chronic Liver Disease. Hepatol Commun 2020;4:1562-77. [PMID: 33163829 DOI: 10.1002/hep4.1612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kochar B, Ufere NN, Ritchie CS, Lai JC. The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis. Clin Transl Gastroenterol 2022. [PMID: 35080513 DOI: 10.14309/ctg.0000000000000445] [Reference Citation Analysis]
2 Weersink RA, Hayward KL. Collaboration Is Needed to Translate Pharmacology Data Into Better Health Outcomes in Chronic Liver Disease. Hepatol Commun 2021;5:715-6. [PMID: 33860129 DOI: 10.1002/hep4.1663] [Reference Citation Analysis]
3 Ferreira V, Vincelette C, Mathieu A. Joint Efforts to Ensure Evidence-Based Decisions by Clinicians in Drug Adjustment for Chronic Liver Disease Populations. Hepatol Commun 2021;5:713-4. [PMID: 33860128 DOI: 10.1002/hep4.1664] [Reference Citation Analysis]
4 Hayward KL, Valery PC, Patel PJ, Li C, Horsfall LU, Wright PL, Tallis CJ, Stuart KA, David M, Irvine KM, Cottrell N, Martin JH, Powell EE. Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety. Pharmaceuticals (Basel) 2021;14:1207. [PMID: 34959611 DOI: 10.3390/ph14121207] [Reference Citation Analysis]